Vilanterol 25.00 MCG + Fluticasone Furoate 100.00 MCG

TRELEGY ELLIPTA is a fixed-dose combination inhaler used for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD). It contains Vilanterol, a long-acting beta2-adrenergic agonist (LABA), and Fluticasone Furoate, a corticosteroid. Vilanterol acts by relaxing the muscles in the airways, while Fluticasone Furoate reduces inflammation in the airways. Together, they help improve breathing and reduce symptoms such as wheezing, shortness of breath, and coughing. TRELEGY ELLIPTA is not a rescue inhaler and should not be used to treat sudden asthma attacks. It should be used regularly as prescribed by a healthcare professional to control and prevent symptoms.

Always follow the instructions provided with the inhaler and use TRELEGY ELLIPTA exactly as prescribed. Shake the inhaler well before each use. Breathe out fully, place the inhaler mouthpiece in your mouth, and close your lips around it. Inhale deeply and forcefully through your mouth to deliver the medication into your lungs. Hold your breath for 10 seconds and then exhale slowly. Rinse your mouth with water after each use to prevent the risk of oral candidiasis.

Allopathic

The contents and information provided here are solely intended to provide a general overview of the products and medicines and must be used for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. The information contained herein should not be used as a substitute for the advice of a qualified physician. For all queries or doubts related to your medical condition, we highly recommend that you consult your registered medical practitioner.